Acute defibrillation performance of a novel, non-transvenous shock pathway in adult ICD indicated patients

Heart Rhythm

Volumn 5, Issue 1, 2008, Pages 28-34

  Lieberman, Randy ^a   Havel, William J ^b   Rashba, Eric ^c   DeGroot, Paul J ^b   Stromberg, Kurt ^b   Shorofsky, Stephen R ^c  

^a HARPER UNIVERSITY HOSPITAL   (United States)

^b MEDTRONIC INC   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Defibrillation; Implantable Defibrillator; Subcutaneous Electrodes; Sudden Cardiac Death; Ventricular Fibrillation

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DEFIBRILLATION; DEFIBRILLATOR; DYSPLASIA; ELECTRODE; ELECTROSTIMULATION; FEASIBILITY STUDY; FEMALE; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMPEDANCE; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; SARCOIDOSIS; SUDDEN DEATH; SYNCOPE; TREATMENT INDICATION; WAVEFORM;

ACUTE DISEASE; AGE FACTORS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; ELECTRODES; FEMALE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR FIBRILLATION;

EID: 37549050873     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2007.08.030     Document Type: Article

References (40)

1. Smith T.W., and Cain M.E. Sudden cardiac death: epidemiologic and financial worldwide perspective. J Interv Card Electrophysiol (2007) [Epub ahead of print]
2. Zheng Z.J., Croft J.B., Giles W.H., and Mensah G.A. Sudden cardiac death in the United States, 1989 to 1998. Circulation 104 (2001) 2158-2163
3. Bardy G.H., Lee K.L., Mark D.B., Poole J.E., Packer D.L., Boineau R., Domanski M., Troutman C., Anderson J., Johnson G., McNulty S.E., Clapp-Channing N., Davidson-Ray L.D., Fraulo E.S., Fishbein D.P., Luceri R.M., and Ip J.H. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. The New England Journal of Medicine 352 (2005) 225-237
4. Buxton A.E., Lee K.L., DiCarlo L., Gold M.R., Greer G.S., Prystowsky E.N., O'Toole M.F., Tang A., Fisher J.D., Coromilas J., Talajic M., and Hafley G. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. N Engl J Med 342 (2000) 1937-1945
5. Moss A.J., Hall W.J., Cannom D.S., Daubert J.P., Higgens S.L., Klein H., Levine J.H., Saksena S., Waldo A.L., Wilber D., Brown M.W., and Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335 (1996) 1933-1940
6. Moss A.J., Zareba W., Hall W.J., Klein H.U., Wilber D.J., Cannom D.S., Daubert J.P., Higgins S.L., Brown M.W., and Andrews M.L. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
7. Tamam M., Modi S., and Lieberman R. Stent and ICD referral patterns following catheterization in patients with low LVEF: low compliance with ICD clinical practice guidelines. Heart Rhythm 3 (2006) S9
8. Anvari A., Stix G., Grabenwoger M., Schneider B., Turel Z., and Schmidinger H. Comparison of three cardioverter defibrillator implantation techniques: initial results with transvenous pectoral implantation. Pacing Clin Electrophysiol 19 (1996) 1061-1069
9. Lawton J.S., Ellenbogen K.A., Wood M.A., Stambler B.S., Spratt J.A., Wechsler A.S., and Damiano R.J. Clinical experience with nonthoracotomy cardioverter defibrillators. Ann Thorac Surg 59 (1995) 1092-1099
10. Saksena S. Defibrillation thresholds and perioperative mortality associated with endocardial and epicardial defibrillation lead systems. Pacing Clin Electrophysiol 16 (1993) 202-207
11. Kleemann T., Becker T., Doenges K., Vater M., Senges J., Schneider S., Saggau W., Weisse U., and Seidl K. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation 115 (2007) 2474-2480
12. Alter P., Waldhans S., Plachta E., Moosdorf R., and Grimm W. Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. Pacing Clin Electrophysiol 28 (2005) 926-932
13. Gold M.R., Peters R.W., Johnson J.W., and Shorofsky S.R. Complications associated with pectoral implantation of cardioverter defibrillators. Pacing Clin Electrophysiol 20 (1997) 208-211
14. Kron J., Herre J., Renfroe E.G., Patron C.R., Raitt M., Halperin B., Gold M., Goldner B., Wathen M., Wilkoff B., Olarte A., and Yao Q. Lead- and device-related complications in the antiarrhythmics versus implantable defibrillators trial. Am Heart J 141 (2001) 92-98
15. Schuder J.C., Stoeckle H., Gold J.H., West J.A., and Keskar P.Y. Experimental ventricular defibrillation with an automatic and completely implanted system. Trans Amer Soc Artif Int Organs 16 (1970) 207-212
16. Berul C.I., Triedman J.K., Forbess J., Bevilacqua L.M., Alexander M.E., Dahlby D., Gilkerson J.O., and Walsh E.P. Minimally invasive cardioverter defibrillator implantation for children: an animal model and pediatric case report. Pacing Clin Electrophysiol 24 (2001) 1789-1794
17. Luedemann M., Hund K., Stertmann W.A., Michel-Behnke I., Gonzales M., Akintuerk H., and Schranz D. Implantable cardioverter defibrillator in a child using single subcutaneous array lead and an abdominal active can. Pacing Clin Electrophysiol 27 (2004) 117-119
18. Madan N., Gaynor J.W., Tanel R., Cohen M., Nicholson S., Vetter V., and Rhodes L. Single-finger subcutaneous defibrillation lead and "active-can": A novel minimally invasive defibrillation configuration for implantable cardioverter-defibrillator implantation in a young child. J Thorac Cardiovasc Surg 126 (2003) 1657-1659
19. Osswald B.R., Tochtermann U., Tanzeem A., and Hagl S. Minimal touch surgical implantable cardioverter defibrillator implantations. Interactive Cardiovasc and Thorac Surg 5 (2006) 343-344
20. Stephenson E.A., Batra A.S., Knilans T.K., Gow R.M., Gradaus R., Balaji S., Dubin A.M., Rhee E.K., Ro P.S., Thogersen A.M., Cecchin F., Triedman J.K., Walsh E.P., and Berul C.I. A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population. Journal of Cardiovascular Electrophysiology 17 (2006) 41-46
21. Grace A.A., Smith W.M., Hood M., Connelly D., Wright J., Fynn S., Crozier I., Melton I., Cappato R., and Bardy G.H. A prospective, randomised comparison in humans of defibrillation efficacy of a standard transvenous ICD system with a totally subcutaneous implantable defibrillator system (S-ICD). European Society of Cardiology (2005) Stockholm, Sweden
22. Burke M.C., Coman J.A., Cates A.W., Lindstrom C.C., Sandler D.A., Kim S.S., and Knight B.P. Defibrillation energy requirements using a left anterior chest cutaneous to subcutaneous shocking vector: Implications for a total subcutaneous implantable defibrillator. Heart Rhythm 2 (2005) 1332-1338
23. DeGroot P.J., Church T., Mehra R., Martinson M., and Schaber D. Derivation of a defibrillator implant criterion based on probability of succesful defibrillation. Pacing Clin Electrophysiol 20 (1997) 1924-1935
24. Malkin R.A., Herre J., McGowen L., Tenzer M., Onufer J., Stamato N., Wood M.A., and Bernstein R. A four-shock Bayesian up-down estimator of the 80% effective defibrillation dose. J Cardiovasc Electrophysiol 10 (1999) 973-980
25. Malkin R.A., Souza J.J., and Ideker R.E. The venticular defibrillation and upper limit of vulnerability dose-response curves. Journal of Cardiovascular Electrophysiology 8 (1997) 895-903
26. Sullivan J.L., Melnick S.B., Chapman F.W., and Walcott G.P. Porcine defibrillation thresholds with chopped biphasic truncated exponential waveforms. Resuscitation (2007) In Press
27. Spiegelhalter J., Abrams K.R., and Myles J.P. Bayesian approaches to clinical trials and health-care evaluation (2004), John Wiley & Sons, Ltd, West Sussex, England
28. Kirchhof P., Eckardt L., Loh P., Weber K., Fischer R.J., Seidl K., Bocker D., Breithardt G., Haverkamp W., and Borggrefe M. Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial. Lancet 360 (2002) 1275-1279
29. Szili-Torok T., Theuns D., Verblaauw T., Scholten M., Kimman G., Res J., and Jordaens L. Transthoracic defibrillation of short-lasting ventricular fibrillation: a randomised trial for comparison of the efficacy of low-energy biphasic rectilinear and monophasic damped sine shocks. Acta Cardiol 57 (2002) 329-334
30. Gradaus R., Block M., Seidl K., Brunn J., Isgro F., Hammel D., Hauer B., Breithardt G., and Bocker D. Defibrillation efficacy comparing a subcutaneous array electrode versus an "Active Can" implantable cardioverter defibrillator and a subcutaneous array electrode in addition to an "Active Can" implantable cardioverter defibrillator: results from Active Can versus Array Trials I and II. J Cardiovasc Electrophysiol 12 (2001) 921-927
31. Schuchert A., Winter J., Binner L., Kuhl M., and Meinertz T. Intraoperative comparison of a subthreshold test pulse with the standard high-energy shock approach for the measurement of defibrillation lead impedance. J Cardiovasc Electrophysiol 17 (2006) 56-59
32. Kerber R.E., Martins J.B., Kienzle M.G., Constatin L., Olshansky B., Hopson R., and Charbonner F. Energy, current and success in defibrillation and cardioversion: clinical studies using an automated impedance-based method of energy adjustment. Circulation 77 (1988) 1038-1046
33. Levine P., and Love C.J. Pacemaker diagnostic and evaluation of pacing system malfunction. In: Ellenbogen K.A., Kay G.N., and Wilkoff B. (Eds). Clinical Cardiac Pacing and Defibrillation (2000), Saunders, Philadelphia 827-875
34. Nelson R., Gilman B., and Shapland E. Leads for the ICD. In: Kroll M.W., and Lehmann M.H. (Eds). Implantable cardioverter defibrillator therapy. The engineering-clinical interface (1996), Kluwer, Norwell 173-204
35. Pavia S., and Wilkoff B. The management of surgical complications of pacemaker and implantable carioverter-defibrillators. Curr Opin Cardiol 16 (2001) 66-71
36. Kettering K., Mewis C., Dornberger V., Vonthein R., Bosch R.F., Seipel L., and Kuhlkamp V. Long-term experience with subcutaneous ICD leads: a comparison among three different types of subcutaneous leads. Pacing Clin Electrophysiol 27 (2004) 1355-1361
37. Sweeney M.O. Subcutaneous defibrillation leads: long term stability of DFT, effect of late position changes, and implications for totally subcutaneous defibrillators. Heart Rhythm 4 (2007) S219
38. Swerdlow C., Brewer J., Kass R., and Kroll M. Application of models of defibrillation to human defibrillation data: Implications for optimizing implantable defibrillator capacitance. Circulation 96 (1997) 2813-2822
39. Block M., Hammel D., Bocker D., Borggrefe M., Budde T., Isbruch F., Scheld H.H., and Breithardt G. Biphasic defibrillation using a single capacitor with large capacitance: reduction of peak voltages and ICD device size. PACE 19 (1996) 207-214
40. Brugada J., Herse B., Sandstedt B., Michel U., Schubert B., and Hahn S.J. Clinical evaluation of defibrillation efficacy with a new single-capacitor biphasic waveform in patients undergoing implantation of an implantable cardioverter defibrillator. Europace 3 (2001) 278-284